WO2015012424A1 - 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 - Google Patents
오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 Download PDFInfo
- Publication number
- WO2015012424A1 WO2015012424A1 PCT/KR2013/006666 KR2013006666W WO2015012424A1 WO 2015012424 A1 WO2015012424 A1 WO 2015012424A1 KR 2013006666 W KR2013006666 W KR 2013006666W WO 2015012424 A1 WO2015012424 A1 WO 2015012424A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- organogel
- oil
- organogel composition
- composition
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to an organogel composition and an organogel mask pack prepared using the same, and more particularly, to an organogel composition having excellent percutaneous absorption properties of the skin active ingredients collected in the organogel, An organogel mask pack.
- organogel was first used to describe the specific concept of gelation of oil in water inverse microemulsions (Luisi et al., Colloid & Polymer Science, 1990, vol. 268, pp. 356-374).
- Organogel has a lamellar phase similar to the skin structure and is characterized by having a gel form without a gelling agent.
- the lecithin organogel has a skin affinity because of its lamellar structure similar to that of the skin, and has been applied to a variety of cosmetic compositions because it can maintain moisture for the skin for a long time.
- Korean Patent No. 0843155 discloses a skin whitening cosmetic composition in which vitamin C is stabilized with lecithin gel, a lecithin-organo gel structure, and Korean Patent No. 0824212 captures the placenta in an organogel.
- the cosmetic composition for skin protection stabilized by stabilizing is disclosed.
- one aspect of the present invention is to provide an organogel composition to facilitate the percutaneous absorption of the skin active ingredient trapped in the organogel.
- Another aspect of the present invention is to provide an organogel mask pack prepared using the organogel composition as described above.
- an organogel composition comprising an oil, an oil gelling agent, a polyhydric alcohol, water, a gelling polymer and an active skin component.
- an organogel mask pack prepared using the organogel composition is provided.
- the organogel composition according to the present invention since the organogel structure has a lamellar structure similar to that of the skin, skin affinity is improved, and thus, the delivery of the active ingredient of the skin can be easily and quickly performed.
- the organogel composition according to the present invention since the organogel composition according to the present invention has a relatively high oil content, it is easy to deliver various useful skin active ingredients, and can maintain skin moisture for a long time, thereby reducing the loss of transdermal moisture.
- an organogel composition which can be easily transdermally absorbed skin active ingredient collected in the organogel.
- the organogel composition according to the present invention includes an oil, an oil gelling agent, a polyhydric alcohol, water, a gelling polymer and an active ingredient of the skin.
- the oil which may be used in the present invention is isopropyl myristate, ethyl laurate, ethyl myristate, isopropyl palmitate, cyclopentane, cyclooctane, trans-decalin, n-pentane, n-hexane, n-hexadecane, Tripropylamine, 1,7-octadiene, butyllaurate, cyclododecane, dibutyl ether, isooctane, n-octane, tributylamine, triisobutylamine, polyol esters, triglycerides, diglycerides, monoglycerides May be one or more selected from the group consisting of lides, diglycerides, and fatty acid esters, furthermore caprylic / capric triglycerides, butyleneglycoldicaprylate / dicaprate, triethyl
- ester oils such as caprylic / capric triglyceride, butylene glycol dicaprylate / dicaprate, triethylhexanoin, cetylethylhexanoate, isopropyl myristate, octyldodecanol and the like are used. do.
- the oil may be included in an amount of 5 to 45% by weight, more preferably in an amount of 10 to 30% by weight, based on the total weight of the organogel composition for the mask pack.
- the oil is included in less than 10% by weight based on the total weight of the organogel composition for the mask pack it is difficult to form the desired organogel because the content of the oil is relatively small, and thus the desired skin active ingredient If the transdermal absorption rate tends to be lowered and is included in an amount exceeding 45% by weight, the oil is separated from the aqueous phase, thereby making it difficult to manufacture the final mask pack.
- the oil gelling agent may be at least one selected from the group consisting of lecithin, pluronic lecithin, sorbitan fatty acid esters, gelatin, L-lysine, limonene, and polyethylene, and mixtures thereof may also be used. .
- the oil gelling agent may be included in an amount of 0.1 to 10% by weight, more preferably 3 to 7% by weight, based on the total weight of the organogel composition for the mask pack.
- the oil gelling agent is added in less than 0.1% based on the total weight of the organogel composition for the mask pack, there is a problem that the oil is separated from the water phase without being mixed with the aqueous phase, and when included in excess of 10% by weight There is a problem that the elasticity of the obtained organogel falls.
- the polyhydric alcohol which can be used in the present invention is used as a solvent with water, at least one selected from the group consisting of polyhydric alcohols such as glycerin, ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, or It may be a mixture.
- polyhydric alcohols such as glycerin, ethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, or It may be a mixture.
- the polyhydric alcohol may be included in an amount of 0.5 to 35% by weight based on the total weight of the organogel composition, more preferably in an amount of 5 to 15% by weight. If it is less than 0.5% by weight, the dispersion of the gelling polymer tends to be difficult, and if it is more than 35% by weight, the gel content decreases over time because the water content is relatively low, and the stickiness is excessive when applied to the skin. Tends to increase.
- the water contained in the organogel of the present invention is included in the amount of the balance, that is, the water is added in the final amount of 100% by weight of the total composition.
- the gelling polymer is such as galactomannan, glucomannan, guar gum, locust bean gum, pluronic, agar, algin, carrageenan, xanthan, gellan, gelatin, methylcellulose, cellulose, carboxymethylcellulose, and hydroxyethylcellulose Natural sugars; At least one selected from the group consisting of hydrophilic gelling agents such as polyacrylates or salts thereof, polymethacrylic acid, carboxyvinyl polymers, polyvinyl alcohols, polyacrylamides, polyethylene oxides, polyethyleneimines, polyvinylpyrrolidones Mixture.
- hydrophilic gelling agents such as polyacrylates or salts thereof, polymethacrylic acid, carboxyvinyl polymers, polyvinyl alcohols, polyacrylamides, polyethylene oxides, polyethyleneimines, polyvinylpyrrolidones Mixture.
- the gelling polymer may be included in an amount of 0.1 to 10% by weight, more preferably 0.5 to 5% by weight, based on the total weight of the organogel composition of the present invention.
- the water-soluble polymer is added at less than 0.1% by weight based on the total weight of the organogel composition, it is possible to maintain the shape of the gel, but the strength of the gel is high and the flexibility is low, resulting in poor adhesion to the skin and exceeding 20% by weight.
- the gel is liable to be difficult to maintain the shape and elasticity is difficult to manufacture a problem.
- a crosslinked matrix may be obtained by adding at least two gelling polymers, and the matrix thus prepared is preferable for maintaining the form of the organogel when used as a skin care pack.
- a branched polymer selected from the group consisting of galactomannan, glucomannan, guar gum, locust bean gum, and pluronic It is preferable to mix at least 1 type or more of each selected electrolyte polymer.
- the electrolytic gelling polymer serves to maintain the composition of the present invention at normal room temperature (about 20 °C), preferably in a gel state at a temperature of 0-30 °C, branched gelling polymer when the temperature rise, That is, at 10-50 ° C., preferably at about 30-40 ° C. near the body temperature, the organogel of the present invention may be changed into a fluid state, and may be effectively applied to the skin.
- the branched gelling polymer and the electrolytic gelling polymer is preferably contained in 0.05-10% by weight and 0.05-5% by weight, respectively, based on the total weight of the composition, if out of this range, the gel is not formed Alternatively, even if the temperature is increased, the gel state may not change into a flow state.
- the gelling polymer may be mixed with at least one or more crosslinking agents selected from acrylic polymers, styrene copolymers, and mixtures thereof, and a component preferred as the crosslinking agent may be, for example, sodium.
- cross-linking agent When the cross-linking agent is added, such a cross-linking agent not only serves to further improve the physical properties of the organo gel of the present invention, but also to form a thin film to better adhere to when used on the skin and maintain moisture effectively It may also serve to provide a soft texture to the organo gel of the present invention.
- the crosslinking agent may be added at 0.01 to 5% by weight based on the total weight of the organogel composition.
- the skin active ingredient that may be included in the organogel composition for the mask pack is retinol, retinyl palmitate, retinyl acetate, retinoic acid, coenzyme qtene, elastin, collagen, hyaluronic acid, ceramide, collagen, caffeine, chitosan, ascorbic acid At least one selected from the group consisting of binic acid, ascorbylglucoside, alphabisabolol, tocopherol, tocopherol acetate, arbutin, niacinamide, adenosine, retinol acetate, vitamins A, D, E, and other natural extracts; It is preferable to use a mixture thereof.
- organogel composition for a mask pack according to the present invention when preparing a mask pack using the organogel composition for a mask pack according to the present invention, in particular, useful components such as tocopherol acetate, retinol acetate, vitamin A, D, E, ceramide, coenzymecuten, and alpha bisabolol, transdermal absorption rate This can be significantly improved.
- the natural extract is aloe, green tea, ginseng, red ginseng, vinegar, pine needles, ginkgo biloba, propolis, mulberry leaves, silkworm, snail slime, kakadu plum, camu camu, yasa yam, squalane, caviar, broccoli, blueberry, witch hazel , Acerola, Chlorella, Mangosteen, Guava, Cornus, Carrot, Caffeine, Hamamelis, Spirulina, Salmon Roe, Ecklonia cava, Giant Kelp, Packing, Macchi, Seaweed, Wood Starfish, Mulberry Root, Raspberry, Raspberry It is preferably one or more selected from the group consisting of edelweiss, chamomile, lavender, peppermint, eucalyptus, lemon balm, oregano, tea tree, golden, edible herb, mountain hawthorn, and citron.
- the skin active ingredient may be included in an amount of 0.05 to 10% by weight, more preferably 2 to 5% by weight, based on the total weight of the composition.
- the skin beauty effect is insignificant, and when included in excess of 20% by weight may cause skin irritation.
- pH adjusting agents such as citric acid, potassium hydroxide and arginine
- Preservatives such as parabens such as methylparaben and propylparaben and phenoxyethanol
- Metal ion sequestrants such as 2Na EDTA
- Other additives such as moisturizers such as betaine, sorbitol, 1,2-hexanediol, erythritol and the like can be added.
- the other additives may be included in an amount of 0.01 to 10% by weight, and more preferably 0.05 to 5% by weight, based on the total weight of the organogel composition of the present invention.
- the organogel according to the present invention has a lamellar structure similar to that of the skin, skin affinity is improved, thereby allowing the skin active ingredient to be easily and quickly transferred from the organogel to the skin. Furthermore, the organogel according to the present invention has a relatively high oil content and is easy to deliver useful skin active ingredients, and can maintain skin moisture for a long time, thereby reducing transdermal moisture loss.
- the mask pack using the organogel composition according to the present invention can be prepared by the following process.
- additives are mixed and heated to about 70-80 ° C. to dissolve the components.
- the mixture obtained by adding the gelled polymer, the skin beauty ingredient, and the polyhydric alcohol to the remainder of the water was added, mixed, and stirred to form a uniform solution.
- a crosslinking agent can be further added as needed. If the temperature is less than 70 °C component is added to water is not completely dissolved, if more than 80 °C may be the stability of some additives or natural components.
- water may be added in an appropriate amount so that each component may be easily dissolved in the final amount of the total composition to 100% by weight.
- an oil heated to about 70 to 80 ° C., and a mixture to which an oil gelling agent was added are slowly added dropwise to the mixed solution with stirring to prepare an organogel solution.
- other additives such as preservatives may be further included.
- the organogel solution thus obtained is coated on a support, then cooled to room temperature, and molded into a desired shape to prepare an organogel mask pack.
- the support may be nylon, rayon, nonwoven fabrics, and the like, preferably rayon mesh fabric.
- the organogel mask pack may be molded into a desired shape suitable for body parts such as face, eyes, cheeks, chin, neck, etc. to obtain a final organogel mask pack. Furthermore, both sides of the organogel mask pack may be Can be protected with film
- the organogel composition coated on the support is preferably a thickness of 0.01 to 50mm, if the thickness is less than 0.01mm may cause a problem that the gel is torn when attached to the skin, the active ingredient included in the gel Since the amount is small, there is a problem that they are not sufficiently delivered to the skin, and if it exceeds 50mm, because the gel is excessively thick, there is a problem of poor adhesion to the skin.
- EDTA 2Na, betaine and methylparaben were mixed in the first purified water and heated to about 75 to 80 ° C. to dissolve the components.
- the solution which mixed niacinamide, butylene glycol, glycerin, carrageenan, and locustvin gum was added and mixed to 2nd purified water.
- the respective contents of the components are as described in Table 1 below.
- the organogel solution was coated with a rayon mesh fabric as a wick and coated on both sides, and then molded into a desired shape to prepare an organogel mask pack.
- Example 1 One First purified water 43.62 80.02 2 EDTA 2Na 0.01 0.01 3 Betaine 0.5 0.1 4 Methylparaben 0.2 0.2 5 Second purified water 10 10 6 Niacinamide 2 2 7 Butylene Glycol (1,3) 2 - 8 glycerin 5 0.5 9 Locust bean sword 1.2 1.2 10 Carrageenan 0.45 0.45 11 MCT (Caprylic / Capric Triglyceride) 30 5 12 lecithin 5 0.5 13 Propylparaben 0.02 0.02
- EDTA 2Na, sorbitol, methylparaben and sodium acrylate / C 10-30 alkyl acrylate crosspolymer were mixed in the first purified water and heated to about 75 to 80 ° C. to dissolve the components.
- the solution which mixed tocopherol acetate, glycerin, carrageenan, and locustbin gum was added and mixed to 2nd purified water.
- the respective contents of the components are as shown in Table 2 below.
- an organogel solution was prepared by dropwise addition of butyleneglycoldicaprylate / dicaprate or a mixture of triethylhexanoin and lecithin heated to 75-80 ° C. with stirring.
- the organogel solution was coated with a rayon mesh fabric as a wick and coated on both sides, and then molded into a desired shape to prepare an organogel mask pack.
- Example 4 One First purified water 67.62 60.57 2 EDTA 2Na 0.01 0.01 3 Sorbitol 0.5 0.5 4 Methylparaben 0.2 0.2 5 Second purified water 10 10 6 Tocopherol Acetate 2 2 7 glycerin 2 4 8 Locust bean sword 1.2 0.5 9 Carrageenan 0.45 0.2 10 Butylene Glycol Dicaprylate / Dicaprate 15 - Triethylhexanoin - 20 11 lecithin One 2 12 Sodium Acrylate / C10-30 Alkylacrylate Crosspolymer 0.02 0.02
- EDTA 2Na, sorbitol, butylene / ethylene / styrene copolymer and methylparaben were mixed in the first purified water and heated to about 75 to 80 ° C. to dissolve the components.
- the solution which mixed alpha bisabolol, glycerin, carrageenan, and glucomannan to the 2nd purified water was added and mixed.
- each content of the above components is as described in Table 3 below.
- the organogel solution was coated with a rayon mesh fabric as a wick and coated on both sides, and then molded into a desired shape to prepare an organogel mask pack.
- Example 5 One First purified water 51.62 43.62 2 EDTA 2Na 0.01 0.01 3 Sorbitol 0.5 0.5 4 Methylparaben 0.2 0.2 5 Second purified water 10 10 6 Alpha-bisabolol 2 2 7 glycerin 6 8 8 Glucomannan 1.2 1.2 9 Carrageenan 0.45 0.45 10 Cetylethylhexanoate 25 - Isopropyl myristate 30 11 lecithin 3 - Pluronic Lecithin - 4 12 Butylene / Ethylene / Styrene Copolymer 0.02 0.02
- EDTA 2Na, sorbitol, butylene / ethylene / styrene copolymer and methylparaben were mixed in the first purified water and heated to about 75 to 80 ° C. to dissolve the components.
- the solution which mixed alpha bisabolol, glycerin, glucomannan and gellan or carrageenan was added and mixed to 2nd purified water.
- each content of the above components is as described in Table 4 below.
- the organogel solution was coated with a rayon mesh fabric as a wick and coated on both sides, and then molded into a desired shape to prepare an organogel mask pack.
- Example 7 One First purified water 38.02 30.30 2 EDTA 2Na 0.01 0.01 3 Sorbitol 0.5 0.5 4 Methylparaben 0.2 0.2 5 Second purified water 10 10 6 Alpha-bisabolol 0.1 2.0 7 glycerin 10 12 8 Glucomannan 1.2 1.2 9 Carrageenan 0.45 - Guerlan - 0.45 10 Cetylethylhexanoate 35 - Isopropyl myristate - 40 11 lecithin 4.5 - Pluronic Lecithin 3.5 12 Butylene / Ethylene / Styrene Copolymer 0.02 0.02
- EDTA 2Na, betaine and methylparaben were mixed in the first purified water and heated to about 75 to 80 ° C. to dissolve the components.
- the solution which mixed tocopherol acetate, glycerin, locust bean gum, and carrageenan was added and mixed to 2nd purified water.
- the respective contents of the components are as described in Table 5 below.
- the organogel solution was coated with a rayon mesh fabric as a wick and coated on both sides, and then molded into a desired shape to prepare an organogel mask pack.
- the organogel was cut into a 10 mm diameter circle, and the initial weight thereof was measured. Then, the organogel was attached to the inside of the upper arm of 20 healthy women for 30 minutes, and then detached. In order to prevent evaporation of moisture, a vinyl of the same size as the organogel was covered and fixed.
- Moisturizing capacity of the organogel-attached skin was measured using Corneometer CM 825 (Courage and Khazaka, Germany), a device that measures capacitance in a non-invasive state of moisture retention.
- the amount of water loss (g / m 2 h) was measured using Tewarmeter TM210 (Courage and khazaka, Germany), a device for measuring transepidermal water loss (TEWL).
- Organogel was cut into a 10 mm diameter circle, attached to the inner arm upper arm of 20 healthy women, detached after 24 hours, and visually evaluated the condition of the skin and evaluated according to the following evaluation criteria. 6 is shown.
- Examples 1 to 4 of the present invention can be confirmed that the excellent moisturizing degree, skin irritation degree and stability.
- Comparative Example 1 the moisturizing degree, skin irritation degree and stability were insufficient, and Comparative Example 2 was unable to measure the physical properties of the formulation itself.
- Organogels prepared according to Examples 3 and 4 and Comparative Example 1 were uniformly attached in a round shape of 20 mm around the eyes twice a day for 20 women aged 40 to 60 years. Experiments were conducted for a total of three months with eyes' crow's feet. The organogel prepared in Example 3 or 4 was applied to the left eye of the test subject, and the composition prepared in Comparative Example 1 was applied to the right eye.
- the depth of wrinkles was measured by using an image analysis method in relation to the eye wrinkle wrinkle (replica) before and after application of the organogel, and as a result, the wrinkle depth reduction rate is shown in Table 9 below.
- the organogel prepared according to the present invention can be confirmed that the transdermal absorption efficiency is excellent and also effective in improving wrinkles.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
NO. | 원료명 | 실시예1 | 실시예 2 |
1 | 제1 정제수 | 43.62 | 80.02 |
2 | EDTA 2Na | 0.01 | 0.01 |
3 | 베타인 | 0.5 | 0.1 |
4 | 메틸파라벤 | 0.2 | 0.2 |
5 | 제2 정제수 | 10 | 10 |
6 | 니아신아미이드 | 2 | 2 |
7 | 부틸렌글리콜 (1,3) | 2 | - |
8 | 글리세린 | 5 | 0.5 |
9 | 로카스트빈 검 | 1.2 | 1.2 |
10 | 카라기난 | 0.45 | 0.45 |
11 | MCT (Caprylic/Capric Triglyceride) | 30 | 5 |
12 | 레시틴 | 5 | 0.5 |
13 | 프로필파라벤 | 0.02 | 0.02 |
NO. | 원료명 | 실시예3 | 실시예 4 |
1 | 제1 정제수 | 67.62 | 60.57 |
2 | EDTA 2Na | 0.01 | 0.01 |
3 | 소르비톨 | 0.5 | 0.5 |
4 | 메틸파라벤 | 0.2 | 0.2 |
5 | 제2 정제수 | 10 | 10 |
6 | 토코페롤아세테이트 | 2 | 2 |
7 | 글리세린 | 2 | 4 |
8 | 로카스트빈 검 | 1.2 | 0.5 |
9 | 카라기난 | 0.45 | 0.2 |
10 | 부틸렌글라이콜디카프릴레이트/디카프레이트 | 15 | - |
트리에틸헥사노인 | - | 20 | |
11 | 레시틴 | 1 | 2 |
12 | 소듐아크릴레이트/C10-30알킬아크릴레이트크로스폴리머 | 0.02 | 0.02 |
NO. | 원료명 | 실시예5 | 실시예 6 |
1 | 제1 정제수 | 51.62 | 43.62 |
2 | EDTA 2Na | 0.01 | 0.01 |
3 | 소르비톨 | 0.5 | 0.5 |
4 | 메틸파라벤 | 0.2 | 0.2 |
5 | 제2 정제수 | 10 | 10 |
6 | 알파비사볼롤 | 2 | 2 |
7 | 글리세린 | 6 | 8 |
8 | 글루코만난 | 1.2 | 1.2 |
9 | 카라기난 | 0.45 | 0.45 |
10 | 세틸에틸헥사노에이트 | 25 | - |
이소프로필미리스테이트 | 30 | ||
11 | 레시틴 | 3 | - |
플루로닉 레시틴 | - | 4 | |
12 | 부틸렌/에틸렌/스타이렌공중합체 | 0.02 | 0.02 |
NO. | 원료명 | 실시예7 | 실시예 8 |
1 | 제1 정제수 | 38.02 | 30.30 |
2 | EDTA 2Na | 0.01 | 0.01 |
3 | 소르비톨 | 0.5 | 0.5 |
4 | 메틸파라벤 | 0.2 | 0.2 |
5 | 제2 정제수 | 10 | 10 |
6 | 알파비사볼롤 | 0.1 | 2.0 |
7 | 글리세린 | 10 | 12 |
8 | 글루코만난 | 1.2 | 1.2 |
9 | 카라기난 | 0.45 | - |
겔란 | - | 0.45 | |
10 | 세틸에틸헥사노에이트 | 35 | - |
이소프로필미리스테이트 | - | 40 | |
11 | 레시틴 | 4.5 | - |
플루로닉 레시틴 | 3.5 | ||
12 | 부틸렌/에틸렌/스타이렌공중합체 | 0.02 | 0.02 |
NO. | 원료명 | 비교예 1 | 비교예 2 |
1 | 제1 정제수 | 80.02 | 10.62 |
2 | EDTA 2Na | 0.01 | 0.01 |
3 | 베타인 | 0.5 | 0.5 |
4 | 메틸파라벤 | 0.2 | 0.2 |
5 | 제2 정제수 | 10 | 10 |
6 | 토코페롤아세테이트 | 2 | 2 |
7 | 글리세린 | 2.5 | 15 |
8 | 로카스트빈 검 | 1.2 | 1.2 |
9 | 카라기난 | 0.45 | 0.45 |
10 | MCT (Caprylic/Capric Triglyceride) | 3 | 50 |
11 | 레시틴 | 0.1 | 10 |
12 | 프로필파라벤 | 0.02 | 0.02 |
구분 | 실시예 1 | 실시예 2 | 실시예 3 | 실시예 4 | 비교예 1 | 비교예 2 | |
보습도 | 무게(g) 차이 | 0.3 | 0.35 | 0.2 | 0.21 | 0.28 | 제형불가 |
초기Corneometer 값 (AU) | 32.0 | 29.0 | 28.7 | 30.3 | 27.2 | 제형불가 | |
30분 후Corneometer 값 (AU) | 35.5 | 34.1 | 33.4 | 34.1 | 29.1 | 제형불가 | |
초기 Tewarmeter 값(g/m2h) | 7.0 | 6.5 | 6.5 | 6.5 | 4.7 | 제형불가 | |
30분 후Tewarmeter 값 (g/m2h) | 6.3 | 5.4 | 5.5 | 5.7 | 4.5 | 제형불가 | |
피부자극도 | ◎ | ◎ | ◎ | ◎ | ○ | 제형불가 | |
안정성 | 60분 | ◎ | ◎ | ◎ | ◎ | □ | 제형불가 |
5시간 | ◎ | ◎ | ◎ | ◎ | △ | 제형불가 | |
10시간 | ◎ | ◎ | ◎ | ◎ | X | 제형불가 | |
24시간 | ◎ | ◎ | ◎ | ◎ | X | 제형불가 |
시료 | 실시예 3 | 실시예 4 | 비교예 1 |
투과율 | 15.3% | 16.1% | 7.2% |
구분 | 개선없음 | 약간 개선 | 중간정도의 개선 | 상당한 개선 |
실시예 3 | 1 | 2 | 3 | 4 |
실시예 4 | 0 | 2 | 4 | 4 |
비교예 1 | 3 | 3 | 3 | 1 |
구분 | 실시예 3 | 실시예 4 | 비교예 1 |
도포 전 | 325 ±41 | 308 ±39 | 295 ±35 |
도포 후 90일 경과 | 179 ±41 | 255 ±32 | 276 ±37 |
주름 깊이 감소율 | 14.10% | 17.20% | 6.40% |
Claims (16)
- 오일, 오일 겔화제, 물, 다가알콜, 겔화고분자 및 피부 유효 성분을 포함하는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 오일은 이소프로필미리스테이트, 에틸라우레이트, 에틸미리스테이트, 이소프로필 팔미테이트, 시클로펜탄, 시클로옥탄, 트랜스-데칼린, n-펜탄, n-헥산, n-헥사데칸, 트리프로필아민, 1,7-옥타디엔, 부틸라우레이트, 시클로도데칸, 디부틸에테르, 이소옥탄, n-옥탄, 트리부틸아민, 트리이소부틸아민, 폴리올에스테르, 트리글리세라이드, 디글리세라이드, 모노글리세라이드, 디글리세라이드; 카프릴릭/카프릭트리글리세라이드, 부틸렌글라이콜디카프릴레이트/디카프레이트, 트리에틸헥사노인, 세틸에틸헥사노에이트, 이소프로필미리스테이트, 옥틸도데칸올; 리퀴드파라핀, 바세린, 하이드로제네이티드폴리데센, 스쿠알렌; 마이크로리스탈린왁스, 비즈왁즈, 라놀린왁스; 호호바오일, 아보카도오일, 아몬드오일, 올리브오일, 참기름, 밀배아유, 사플라워오일, 동백기름, 피마자유, 포도씨오일, 녹차씨오일, 마카다미아넛츠오일, 야자유, 로즈힙오일, 경화유, 아르간오일, 산자나무오일, 아르간트리커넬오일, 라벤더오일; 사이클로메치콘, 페닐트리메치콘, 사이클로펜타실록산, 및 디메치콘으로 구성되는 그룹으로부터 선택되는 최소 하나 이상인 오르가노겔 조성물.
- 제 1항에 있어서, 상기 오일은 오르가노겔 조성물의 총 중량을 기준으로, 5 내지 45 중량%의 함량으로 포함되는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 오일 겔화제는 레시틴, 플루로닉 레시틴, 소르비탄 지방산 에스테르, 젤라틴, L-리신(lysine), 리모넨, 및 폴리에틸렌으로 구성되는 그룹으로부터 선택되는 적어도 하나 이상인 오르가노겔 조성물.
- 제 1항에 있어서, 상기 오일 겔화제는 오르가노겔 조성물의 총 중량을 기준으로, 0.1 내지 10 중량%의 함량으로 포함되는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 다가알콜은 글리세린, 에틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 및 부틸렌글리콜로 구성되는 그룹으로부터 선택되는 적어도 하나 이상인 오르가노겔 조성물.
- 제 1항에 있어서, 상기 다가알콜은 오르가노겔 조성물의 총 중량을 기준으로, 0.5 내지 35 중량%의 함량으로 포함되는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 겔화고분자는 갈락토만난, 글루코만난, 구아껌, 로카스트 빈 껌, 플루로닉, 아가, 알긴, 카라기난, 잔탄, 겔란, 젤라틴, 메틸셀룰로오스, 셀룰로오스, 카르복시메틸셀룰로오스, 히드록시에틸셀룰로오스; 폴리아크릴레이트 또는 그의 염, 폴리메타크릴산, 카르복시비닐폴리머, 폴리비닐알코올, 폴리아크릴아미드, 폴리에틸렌옥시드, 폴리에틸렌이민, 폴리비닐피롤리돈으로 구성되는 그룹으로부터 선택되는 적어도 하나 이상인 오르가노겔 조성물.
- 제 1항에 있어서, 상기 겔화고분자는 오르가노겔 조성물의 총 중량을 기준으로, 0.1 내지 10 중량%의 함량으로 포함되는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 피부유효성분은 레티놀, 레티닐팔미테이트, 레티닐 아세테이트, 레티노인산, 코엔자임 큐텐, 엘라스틴, 콜라겐, 히알루론산, 세라마이드, 콜라겐, 카페인, 키토산, 아스코르빈산, 아스코르빌글루코사이드, 알파비사볼롤, 토코페롤, 토코페롤아세테이트, 알부틴, 니아신아마이드, 아데노신, 레티놀아세테이트, 비타민 A, D, E, 및 천연추출물로 구성되는 그룹으로부터 선택되는 적어도 하나 이상인 오르가노겔 조성물.
- 제 10항에 있어서, 상기 천연추출물은 알로에, 녹차, 인삼, 홍삼, 목초액, 솔잎, 은행잎, 프로폴리스, 뽕잎, 누에, 달팽이 점액, 카카두플럼, 카무카무, 야사이야자, 스쿠알란, 캐비어, 브로콜리, 블루베리, 위치하젤, 아세로라, 클로렐라, 망고스틴, 구아바, 산수유, 당근, 카페인, 하마멜리스, 스피룰리나, 연어알, 감태, 자이언트켈프, 곤포, 마치현, 파래, 우뭇가사리, 뽕 나무 뿌리, 라즈베리, 산딸기, 톳, 모자반, 에델바이스, 카모마일, 라벤더, 페퍼민트, 유칼립투스, 레몬밤, 오레가노, 티트리, 황금, 어성초, 산자나무, 및 유자로 이루어지는 그룹으로부터 선택되는 적어도 하나 이상으로부터 추출되는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 피부유효성분은 오르가노겔 조성물의 총 중량을 기준으로, 0.05 내지 10 중량%의 함량으로 포함되는 오르가노겔 조성물.
- 제 1항에 있어서, 상기 오르가노겔 조성물은 소듐아크릴레이트/C10-30알킬아크릴레이트크로스폴리머(Sodium Acrylates/C10-30 Alkyl Acrylate Crosspolymer) 또는 포타슘아크릴레이트/C10-30알킬아크릴레이트크로스폴리머(Potassium Acrylates/C10-30 Alkyl Acrylate Crosspolymer), 아크릴레이트/에틸헥실아크릴레이트/헤마/스타이렌공중합체(Acrylates/Ethylhexyl Acrylate/HEMA/StyreneCopolymer), 부틸렌/에틸렌/스타이렌공중합체(Butylene/Ethylene/Styrene Copolymer), 암모늄아크릴레이트/메틸스타이렌/스타이렌공중합체(Ammonium Acrylates/Methyl Styrene/Styrene Copolymer), 스타이렌/브이피공중합체(Styrene/VP Copolymer) 및 스타이렌/아크릴레이트공중합체(Styrene/Acrylates Copolymer)로 구성되는 그룹으로부터 선택되는 적어도 하나 이상의 가교제를 추가로 포함하는 오르가노겔 조성물.
- 제 13항에 있어서, 상기 가교제는 오르가노겔 조성물의 총 중량을 기준으로, 0.01 내지 5중량%의 함량으로 포함되는 오르가노겔 조성물.
- 제1항 내지 제14항 중 어느 한 항의 오르가노겔 조성물로 형성된 오르가노겔층, 및 지지체를 포함하는 오르가노겔 마스크팩.
- 제15항에 있어서, 상기 오르가노겔층은 상기 지지체 상에 0.01 내지 50mm의 두께로 코팅된 오르가노겔 마스크팩.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2013/006666 WO2015012424A1 (ko) | 2013-07-25 | 2013-07-25 | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 |
CN201380078473.7A CN105407870A (zh) | 2013-07-25 | 2013-07-25 | 有机凝胶组合物及其制备的有机凝胶面膜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2013/006666 WO2015012424A1 (ko) | 2013-07-25 | 2013-07-25 | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015012424A1 true WO2015012424A1 (ko) | 2015-01-29 |
Family
ID=52393451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2013/006666 WO2015012424A1 (ko) | 2013-07-25 | 2013-07-25 | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105407870A (ko) |
WO (1) | WO2015012424A1 (ko) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105476935A (zh) * | 2016-01-25 | 2016-04-13 | 陈佳伟 | 一种美颈护理啫喱 |
CN105748389A (zh) * | 2016-03-04 | 2016-07-13 | 广东芭薇生物科技股份有限公司 | 一种山羊奶活肌面霜及其制备方法 |
CN105769643A (zh) * | 2016-01-27 | 2016-07-20 | 广东芭薇生物科技股份有限公司 | 一种出水保湿霜及其制备方法 |
CN107375047A (zh) * | 2017-07-03 | 2017-11-24 | 李剑峰 | 白藜芦醇‑环糊精包合物凝胶及其制备方法和应用 |
CN113952240A (zh) * | 2021-12-06 | 2022-01-21 | 源一(杭州)生物医药发展有限公司 | 一种高效舒冷水凝胶面膜及其制备方法 |
WO2024090251A1 (en) * | 2022-10-27 | 2024-05-02 | Jntl Consumer Health Kabushiki Kaisha | Cosmetic composition containing microneedles of polymer |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138521A (zh) * | 2016-06-28 | 2016-11-23 | 郑州雷曼药业有限公司 | 一种疤痕修复凝胶及其制备方法 |
KR101829051B1 (ko) * | 2016-10-31 | 2018-02-13 | 주식회사 삼양사 | 점착력이 높고 두꺼운 하이드로겔 시트 |
US11389392B2 (en) | 2017-06-13 | 2022-07-19 | Mary Kay Inc. | Cosmetic compositions and methods for their use in firming skin |
CN108478485A (zh) * | 2018-05-04 | 2018-09-04 | 邵立坤 | 一种温敏型水凝胶面膜及其制备方法 |
CN108721166B (zh) * | 2018-07-20 | 2021-02-09 | 广州睿森生物科技有限公司 | 一种美白组合物、含卡卡杜李提取物的美白保湿精华液及其制备方法 |
CN108992374A (zh) * | 2018-08-06 | 2018-12-14 | 广州睿森生物科技有限公司 | 一种含卡卡杜李提取物的美白抗敏组合物、护肤基质、精华液及其制备方法 |
CN110251448A (zh) * | 2019-06-28 | 2019-09-20 | 江苏蜂奥生物科技有限公司 | 一种含有蜂胶提取物的美容用组合物 |
CN112438931A (zh) * | 2019-09-02 | 2021-03-05 | 山东艾茉农业科技有限公司 | 一种凝胶状面膜及其制备方法 |
CN111437220B (zh) * | 2020-04-29 | 2022-09-06 | 广东聚石化学股份有限公司 | 一种山茶油脂肪酸酯组合物及其制备方法和应用 |
EP4157209A1 (en) * | 2020-05-29 | 2023-04-05 | Unilever IP Holdings B.V. | Cosmetic composition with enhanced color stability for retinoic acid precursor |
CN113967175A (zh) * | 2020-07-24 | 2022-01-25 | 株式会社爱茉莉太平洋 | 片型面膜凝胶组合物、包含其的面膜片及面膜片制备方法 |
CN113509411A (zh) * | 2021-04-23 | 2021-10-19 | 施政宏 | 一种基于山茶籽油的面膜液以及含有该面膜液的面膜 |
CN114344197B (zh) * | 2022-01-13 | 2023-06-09 | 惠州市栢诗新材料有限公司 | 一种阿甘油医用冷敷修复面膜及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070087040A1 (en) * | 1997-12-05 | 2007-04-19 | 3M Innovative Properties Company | Oil cleaning sheets for makeup |
US20080226616A1 (en) * | 2005-07-07 | 2008-09-18 | Jens Schulz | Emulsifier Combination for Cosmetics |
KR20100079347A (ko) * | 2008-12-31 | 2010-07-08 | 주식회사 코리아나화장품 | 샤벳-밤 타입의 유중수형 화장료 조성물 |
KR20130039058A (ko) * | 2011-10-11 | 2013-04-19 | 주식회사 제닉 | 에멀젼화된 하이드로겔 조성물 및 이의 제조방법 |
KR20130045709A (ko) * | 2011-10-26 | 2013-05-06 | 주식회사 제닉 | 쌀가루를 포함하는 경피 흡수용 점착 조성물 및 이의 제조방법 |
KR20130126841A (ko) * | 2012-05-04 | 2013-11-21 | 주식회사 제닉 | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 |
-
2013
- 2013-07-25 CN CN201380078473.7A patent/CN105407870A/zh active Pending
- 2013-07-25 WO PCT/KR2013/006666 patent/WO2015012424A1/ko active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070087040A1 (en) * | 1997-12-05 | 2007-04-19 | 3M Innovative Properties Company | Oil cleaning sheets for makeup |
US20080226616A1 (en) * | 2005-07-07 | 2008-09-18 | Jens Schulz | Emulsifier Combination for Cosmetics |
KR20100079347A (ko) * | 2008-12-31 | 2010-07-08 | 주식회사 코리아나화장품 | 샤벳-밤 타입의 유중수형 화장료 조성물 |
KR20130039058A (ko) * | 2011-10-11 | 2013-04-19 | 주식회사 제닉 | 에멀젼화된 하이드로겔 조성물 및 이의 제조방법 |
KR20130045709A (ko) * | 2011-10-26 | 2013-05-06 | 주식회사 제닉 | 쌀가루를 포함하는 경피 흡수용 점착 조성물 및 이의 제조방법 |
KR20130126841A (ko) * | 2012-05-04 | 2013-11-21 | 주식회사 제닉 | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105476935A (zh) * | 2016-01-25 | 2016-04-13 | 陈佳伟 | 一种美颈护理啫喱 |
CN105769643A (zh) * | 2016-01-27 | 2016-07-20 | 广东芭薇生物科技股份有限公司 | 一种出水保湿霜及其制备方法 |
CN105748389A (zh) * | 2016-03-04 | 2016-07-13 | 广东芭薇生物科技股份有限公司 | 一种山羊奶活肌面霜及其制备方法 |
CN107375047A (zh) * | 2017-07-03 | 2017-11-24 | 李剑峰 | 白藜芦醇‑环糊精包合物凝胶及其制备方法和应用 |
CN113952240A (zh) * | 2021-12-06 | 2022-01-21 | 源一(杭州)生物医药发展有限公司 | 一种高效舒冷水凝胶面膜及其制备方法 |
WO2024090251A1 (en) * | 2022-10-27 | 2024-05-02 | Jntl Consumer Health Kabushiki Kaisha | Cosmetic composition containing microneedles of polymer |
Also Published As
Publication number | Publication date |
---|---|
CN105407870A (zh) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015012424A1 (ko) | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 | |
KR101384999B1 (ko) | 오르가노겔 조성물 및 이를 이용하여 제조된 오르가노겔 마스크 팩 | |
WO2013055041A1 (ko) | 에멀젼화된 하이드로겔 조성물 및 이의 제조방법 | |
WO2018044003A1 (ko) | 안정성이 우수한 수중유형 에멀젼 및 이를 포함하는 화장료 조성물 | |
WO2020022634A1 (ko) | 마스크팩용 액정 유화 조성물, 이의 제조방법 및 이를 함유하는 마스크팩 | |
US20150290110A1 (en) | Sticky hydrogel cosmetic composition | |
WO2014065536A1 (ko) | 가변적 투명도를 갖는 수중유 형태의 오르가노겔 화장료 조성물 | |
KR20140109804A (ko) | 액정 유화 오르가노겔 조성물 및 마스크 팩 | |
WO2014157960A1 (ko) | 파우더를 포함하는 화장료 조성물 및 그 제조방법 | |
WO2020204293A1 (ko) | 자외선 차단용 화장료 조성물 | |
WO2018164309A1 (ko) | 달맞이꽃 추출물을 포함하는 화장품용 조성물 | |
WO2020226347A1 (ko) | 피부 보습 화장료 조성물, 이를 이용한 화장품 및 이의 제조방법 | |
KR101139069B1 (ko) | 내기후성 화장품 착화합물 | |
WO2020218669A1 (ko) | 보습력이 향상된 마스크팩 조성물 | |
WO2018124572A1 (ko) | 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제 | |
WO2020141735A1 (ko) | 고체 유성 성분을 안정화한 저점도 화장료 조성물 | |
WO2020145495A1 (ko) | 수용성 추출물이 흡수된 화장용 캡슐을 포함하는 화장료 조성물 | |
WO2015137647A1 (ko) | 유화제를 함유하지 않는 유화 화장료 조성물 | |
WO2021066510A1 (ko) | 모발 및 두피케어용 트리트먼트 화장료 조성물 및 제조방법 | |
WO2010143802A1 (ko) | 안정한 역상 에멀젼 | |
WO2016140421A1 (ko) | 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체 함유 마이크로캡슐 및 이를 함유하는 화장료 조성물 | |
WO2020218670A1 (ko) | 주름개선력이 향상된 마스크팩 조성물 | |
WO2023033414A1 (ko) | 유효 성분의 포집력이 우수한 리포좀 화장료 조성물 | |
CN113226254A (zh) | 含有视黄醇的水包油型乳化化妆品 | |
WO2023054802A1 (ko) | 히알루론산을 포함하는 유분산 고형 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201380078473.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13889852 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 24/06/2016) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13889852 Country of ref document: EP Kind code of ref document: A1 |